pharmacist supported transitions of care
Budget Impact Analysis of a Pharmacist-Provided Transition of Care Program
j manag care spec pharm. 2018 feb; 24(2):90-96 (open access)
A budget impact analysis was performed to estimate the impact of adding a pharmacist-based transitions-of-care program to a medical benefit from the payer perspective.
Inputs were based on a health plan that services 240,000 lives.
TOC program resulted in
potential cost savings of over $25 million to the managed Medicaid plan over a period of 2 years, corresponding to over
$4 per member per month
The inpatient cost savings were estimated at over $3.5 million in the 6 months after
discharge, with a cumulative
2-year inpatient cost savings of $20.6 million
Reduction of Healthcare costs through a Transitions-of-Care Program
am j Health Syst pharm. 2018 may 15; 75(10); 613-621 (open access)
Use of a pharmacy-based transitions-of-care program leads to a
reduction in 180-day total healthcare costs in high-risk patients
180-day total healthcare costs were $2,139 lower in patients who received an intervention versus the control group.
Estimated savings of nearly
$1.8 million for the managed care plan.
Reductions in Medication-Related Hospitalizations in Older Adults with Medication Management by Hospital
and Community Pharmacists: A Quasi-experimental Study
A state-wide system of medication management services provided by
specially trained hospital and community pharmacists serving high-risk individuals (≥65 years old) from hospitalization through transition to home and for up to 1 year after discharge.
Estimated annual cost of
admissions (≥65 years old)
associated with intervention: $6,626,913
Actual annual cost of
Estimated ROI in pharmacist
Reductions in 30-day Readmission, Mortality, and Costs with Pharmacist Follow-up
Patients discharged from any of 4 hospitals with chronic obstructive
pulmonary disease, pneumonia, heart failure, acute myocardial infarction, or diabetes within Pennsylvania. Patients in the intervention group received consultative services from inpatient pharmacists before discharge and inpatient-to-community pharmacist communication of hospitalization information facilitated with the use of a secure messaging system. After discharge, patients received up to 5 in-person or telephonic medication management consultations with their community
Observed lower 30-day readmission rate, 30-day all-cause mortality, and composite 30-day end point (readmission, ED visit, or death) in intervention group
Estimated average ROI of 8.1 per discharge
Economic Value of Pharmacist-Led Medication Reconciliation for Reducing Medication Errors After Hospital Discharge
Am J Manag Care. 2016 Oct; 22(10): 654-661. (open access)
A pharmacist-led medication reconciliation service at a hospital can reduce medication discrepancies by around 52%, which would lead to an increased cost savings by preventing adverse drug events (ADEs).
The cost of preventable ADEs could be reduced to $206 per patient
Impact of a pharmacy-based transitional care program on hospital readmissions.
am J Manag Care. 2017 Mar; 23(3): 170-176. (open access)
This study evaluates the impact of a community pharmacy-based postdischarge TOC program on hospital readmissions for members of a US managed Medicaid health plan . Over 1100 high-risk patients were referred to Synergy Pharmacy Solutions from the Kern Health Systems managed Medicaid plan between April 2013 and March 2015.
The postdischarge intervention reduced the risk of readmission
Within 30 days: 28%
Reduced number of
readmissions by 6 per
Within 180 days: 31.9%
Reduced number of
readmissions by 19 per